A small clinical trial has shown that a new drug has promise for targeting tumours in patients with an aggressive type of blood cancer.

Imperial scientists have helped unravel the genetic code of tuberculosis (TB), enabling doctors to tailor treatments to each individual patient.

A new study reveals how the global burden of childhood tuberculosis could be reduced by better targeting of high-risk households

Tissues grown in the lab from stem cells may fail to live up their therapeutic promise because the cells choose their own fate.